Updates on autoinflammatory diseases.

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Autoinflammatory diseases are immune dysregulatory conditions originating from innate immune cell dysfunction.
• While often presenting in early life, milder adult-onset forms are increasingly recognized due to advances in genetic testing and diagnostic criteria.
• Therapies targeting proinflammatory cytokines have improved outcomes, driven by the identification of gain-of-function mutations.

Purpose of the Study:

• To review recent advancements in understanding molecular pathways and diseases associated with autoinflammatory conditions.
• To focus on autoinflammatory diseases primarily mediated by Interleukin-1 beta (IL-1β) and Type-I Interferon (IFN).
• To highlight the expanding landscape of autoinflammatory diseases, including those caused by loss-of-function mutations.

Main Methods:

• Review of current scientific literature on autoinflammatory diseases.
• Analysis of genetic findings, including gain-of-function and loss-of-function mutations.
• Focus on molecular pathways involving IL-1β and Type-I IFN.

Main Results:

• Discovery of disease-causing loss-of-function mutations in genes with cellular house-keeping functions.
• Identification of these mutations as triggers for innate inflammatory pathways.
• Confirmation of IL-1β and Type-I IFN as key mediators in a significant subset of autoinflammatory diseases.

Conclusions:

• The understanding of autoinflammatory diseases is evolving beyond gain-of-function mutations to include loss-of-function defects.
• Dysregulation of cellular homeostasis by these mutations can initiate potent inflammatory responses.
• Targeting IL-1β and Type-I IFN pathways remains crucial for managing specific autoinflammatory conditions.